From experimental assays to human clinical samples, BioSIMS offers custom services to drive your drug discovery and diagnostic strategies with a personalized medicine focus.

Our strengths lies on a strong protein microarrays know-how combined with top-class detection technologies.

• For your early stage projects we specialize in lysate microarrays (reverse phase protein microarrays: RPPM) which allows for the simultaneous analyses of multiple target proteins in tens to hundreds of samples. Our platform is of great interest for phospho-activation status and signaling pathways analyses, in cell based assays, fixed tissues or translational research samples.
• Companion diagnostic as well as protein quantification projects will benefit of our custom sandwich protein microarrays development services.

Our research program consists in developing the DigiPLEX® proprietary technology to fulfill the needs of our pharmaceutical, biotech, academics and diagnostic clients. DigiPLEX is a microarray screening platform based on Secondary Ions Mass Spectrometry (SIMS): the most sensitive of all the commonly used surface analysis technologies. It provides a digital quantification with an unmet sensitivity allowing it to quantify proteins down to the femtogram level.